Document is current
Any future updates will be listed below
-
Authors
Huayamares, Sebastian G. https://orcid.org/0000-0003-2859-3074
Lian, Liming
Rab, Regina https://orcid.org/0000-0003-0293-4694
Hou, Yuning https://orcid.org/0000-0001-9894-3821
Radmand, Afsane
Kim, Hyejin https://orcid.org/0000-0002-7937-2733
Zenhausern, Ryan
Achyut, Bhagelu R.
Gilbert Ross, Melissa https://orcid.org/0000-0002-1960-8302
Lokugamage, Melissa P.
Loughrey, David
Peck, Hannah E.
Echeverri, Elisa Schrader https://orcid.org/0000-0003-4094-2054
Da Silva Sanchez, Alejandro J. https://orcid.org/0009-0005-7476-5406
Shajii, Aram
Li, Andrea
Tiegreen, Karen E.
Santangelo, Philip J.
Sorscher, Eric J. https://orcid.org/0000-0001-9341-3354
Dahlman, James E. https://orcid.org/0000-0001-7580-436X
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01DE026941)
- License Information
-
More Information
Article History
Received: 31 August 2023
Accepted: 26 March 2025
First Online: 12 April 2025
Competing interests
: S.G.H., R.R., B.R.A., M.P.L., P.J.S., E.S. and J.E.D. have filed intellectual property related to this manuscript (PCT/US2023/033245). J.E.D. is an advisor to Readout Capital, Edge Animal Health, and Nava Therapeutics. E.J.S. has an ownership interest in PNP Therapeutics, Inc., and serves on the Board of Directors for the company, which develops products used in cancer research. Dr. Sorscher is also an inventor of technology being evaluated in studies described by this report. The terms of this arrangement for Dr. Sorscher have been reviewed and approved by Emory University in accordance with its conflict-of-interest policies. All other authors declare no conflict of interest.
